1400262-29-4Relevant articles and documents
Anti-AIDS agents 90. novel C-28 modified bevirimat analogues as potent HIV maturation inhibitors
Qian, Keduo,Bori, Ibrahim D.,Chen, Chin-Ho,Huang, Li,Lee, Kuo-Hsiung
, p. 8128 - 8136 (2012)
In a continuing study of bevirimat (2), the anti-HIV-maturation clinical trials agent, 28 new betulinic acid (BA, 1) derivatives were designed and synthesized. Among these compounds, 17, with a C-28 MEM ester moiety, and 22, with a C-28 ethyl hexanoate, i